Xencor Stock Price. Everything You Need To Know About The Xencor Stock!
Xencor, Inc. is biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. The company is headquartered in Monrovia California, California and currently employs 281 full-time employees. The company went IPO on 2013-12-03. The firm is focused on discovering and developing engineered monoclonal antibodies and cytokine therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs. The company uses protein engineering capabilities to enable its understanding of protein structures and interactions and to design technologies and XmAb drug candidates with improved properties. The company is advancing its XmAb drug candidates into clinical-stage development. The company is focused on the Fc domain, which is part of an antibody that interacts with various segments of the immune system and controls antibody structural architecture. The Fc domain is constant and interchangeable among antibodies, and its engineered Fc domains are the XmAb technology, which can be readily substituted for natural Fc domains. Its drug candidates include Vudalimab, XmAb104, XmAb564, XmAb819, XmAb808, Plamotamab, Obexelimab, Sotrovimab, XmAb306/RG6323, and others.
Xencor Stock Price. Everything You Need To Know About The Xencor Stock! performance
- Employees 281
- Company HQ Monrovia California
- Website https://xencor.com/
- XNCR Asset Type Common Stock
- XNCR Market Capitalization 1.3B
- Earnings Per Share -2.08
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you a retail investor in Malaysia, Thailand, Indonesia, or Vietnam looking to expand your investment portfolio? Look no further than Xencor. As a leading biopharmaceutical company, Xencor focuses on developing innovative therapies for patients with autoimmune diseases, cancer, and other severe diseases. With a solid track record and a strong pipeline of potential drugs, Xencor has become an attractive opportunity for investors looking for growth potential. Investing in Xencor from Malaysia, Thailand, Indonesia, and Vietnam is now easier than ever with Zorion. As an investment platform, Zorion provides comprehensive investment insights and recommendations to help you make informed decisions. Gain access to educational resources and take advantage of Zorion’s investment expertise to unlock the full potential of investing in Xencor. Start your investment journey today!
